Skip to main content

Charles River Laboratories International, Inc.

CRL
Exchange
NYSE
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001100682

In the last 90 days, Charles River Laboratories International, Inc. insiders filed 0 open-market purchases and 10 sales; 569 institutions reported holding it in 13F filings for Q2 2026, worth $12.9B in total; Harris Associates (Oakmark) is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Charles River Laboratories International, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
6 insiders, $42.6M in total
Insiders trading
6
Net value
−$42.6M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Charles River Laboratories International, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Charles River Laboratories International, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Foster James CDirector31,596Aug 27, 20268
Girshick BirgitChief Executive Officer35,485Aug 20, 20267
Parisotto Shannon MCEVP, Disc & Safety Assessment4,807Aug 20, 20267
Andrews Nancy CDirector1,438Aug 20, 20263
LaPlume Joseph WEVP, Corp Strategy & Develop31,041Aug 11, 20266
Knell Michael GunnarSVP, Finance and CAO11,852Aug 10, 20265
Creamer Victoria LEVP & Chief People Officer30,051Aug 10, 20264
Barg StevenDirector3,287Jun 3, 20262
Coleman GlennEVP & Chief Financial Officer27,752Jun 2, 20262
Mintz MarkEVP, Chief Information Officer9,546Jun 2, 20263
Thompson Craig B.Director3,851May 12, 20261
Graves Paul WDirector2,384May 12, 20261
Wilson Virginia MDirector6,349May 11, 20261
Mackay MartinDirector17,137May 11, 20261
Enyedy Mark JDirector2,384May 11, 20261
Ceesay AbrahamDirector2,384May 11, 20261
Llado George Sr.Director6,702May 11, 20261
Kemps-Polanco ReshemaDirector4,563May 11, 20261
Pease FlaviaCorporate Executive VP & CFO17,297Jun 3, 20250
Massaro GeorgeDirector5,575May 16, 20250
Wallman Richard FDirector0IndirectNov 12, 20240
Barbo William DCorporate Executive VP & CCO23,337IndirectNov 8, 20240
Bertolini Robert JDirector32,802May 15, 20240
Kochevar Deborah TurnerDirector7,894May 15, 20240
Reese C RichardDirector65,541May 17, 20230
Smith David RossCorporate Executive VP & CFO25,819Mar 4, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 6, 2022 (view filing)Dec 24 daysBarbo William DCorporate Executive VP & CCOSSale−3.21K$219.91−$704.8K−45.7%3.80K after4 lots
Dec 5, 2022 (view filing)Dec 14 daysLaPlume Joseph WEVP, Corp Strategy & DevelopSSale−6.41K$224.25−$1.44M−24.1%20.2K after3 lots
Nov 17, 2022 (view filing)Nov 161 dayKnell Michael GunnarCSVP&Chief Accounting OfficerSSale−855$248.59−$212.5K−11.7%6.44K after
Nov 17, 2022 (view filing)Nov 152 daysParisotto Shannon MCEVP, Disc & Safety AssessmentSSale−2.28K$249.90−$569.5K−47.7%2.50K after
Nov 7, 2022 (view filing)Nov 43 daysLaPlume Joseph WEVP, Corp Strategy & DevelopSSale−534$216.36−$115.5K−2.6%20.2K after
Aug 8, 2022 (view filing)Aug 53 daysLaPlume Joseph WEVP, Corp Strategy & DevelopSSale−200$226.13−$45.2K−1.0%20.8K after
May 11, 2022 (view filing)May 92 daysMassaro GeorgeDirectorSSale−178$230.96−$41.1K−3.7%4.68K after7 lots
Mar 4, 2022 (view filing)Mar 31 daySmith David RossCorporate Executive VP & CFOSSale−8.96K$282.53−$2.53M−25.8%25.8K after5 lots
Feb 25, 2022 (view filing)Feb 232 daysFoster James CChairman, President and CEOSSale−20.3K$287.83−$5.84M−8.6%215.0K after13 lots
Feb 24, 2022 (view filing)Feb 231 dayLaPlume Joseph WEVP, Corp Strategy & DevelopSSale−395$292.75−$115.6K−2.0%19.9K after
Feb 23, 2022 (view filing)Feb 221 dayFoster James CChairman, President and CEOSSale−17.4K$288.68−$5.03M−7.4%216.8K after8 lots
Feb 23, 2022 (view filing)Feb 18-225 daysLaPlume Joseph WEVP, Corp Strategy & DevelopSSale−1.54K$291.55−$448.7K−7.0%20.6K after3 lots
Feb 23, 2022 (view filing)Feb 18-225 daysWallman Richard FDirectorSSale−6.05K$292.42−$1.77M−100.0%0 after2 lots
Feb 23, 2022 (view filing)Feb 185 daysWallman Richard FDirectorSSale−1.15K$295.00−$339.3K−6.1%17.7K after2 lots
Feb 17, 2022 (view filing)Feb 152 daysFoster James CChairman, President and CEOSSale−20.0K$315.46−$6.31M−8.4%218.4K after22 lots
Sep 15, 2021 (view filing)Sep 13-142 daysGirshick BirgitCorporate Executive VPSSale−2.42K$439.98−$1.07M−8.1%27.6K after4 lots
Sep 1, 2021 (view filing)Aug 311 dayMassaro GeorgeDirectorSSale−2.54K$442.48−$1.12M−34.3%4.86K after2 lots
Aug 17, 2021 (view filing)Aug 161 dayCreamer Victoria LEVP & Chief People OfficerSSale−6.92K$415.24−$2.87M−52.0%6.39K after
Aug 10, 2021 (view filing)Aug 91 daySmith David RossCorporate Executive VP & CFOSSale−1.75K$407.40−$713.0K−10.8%14.4K after2 lots
Aug 10, 2021 (view filing)Aug 64 daysLaPlume Joseph WEVP, Corp Strategy & DevelopSSale−3.70K$402.21−$1.49M−30.4%8.46K after4 lots
Aug 10, 2021 (view filing)Aug 64 daysBarbo William DCorporate Executive VP & CCOSSale−12.4K$402.82−$4.99M−73.9%4.37K after9 lots
Aug 10, 2021 (view filing)Aug 64 daysKochevar Deborah TurnerDirectorSSale−3.53K$406.43−$1.43M−36.6%6.10K after3 lots
Aug 10, 2021 (view filing)Aug 64 daysFoster James CChairman, President and CEOSSale−10.0K$401.79−$4.02M−4.7%202.3K after5 lots